borderline significanceP=0.19
Notably, the customized ST group exhibited greater alpha power enhancement relative to controls (SMD=0.40, 95% CI: [-0.12, 0.91], P=0.13), indicating potential therapeutic superiority despite borderline significance (I=39%, P=0.19).